Acro Biomedical (ACBM) Payables (2015 - 2026)
Acro Biomedical (ACBM) posted Payables of $63050.0 for Q2 2026, up 13.5% on a QoQ basis from $55550.0 in Q4 2025, and down 33.97% year-over-year from $95493.0 in Q2 2025.
Powered by 
Analysis
Acro Biomedical (ACBM) Payables (2015 - 2026) Analysis & Trends
Acro Biomedical has reported Payables for 12 years, with the latest figure at $63050.0 in Q2 2026.
- On a quarterly basis, Payables fell 33.97% year-over-year to $63050.0 in Q2 2026; TTM through Jun 2026 was $63050.0, a 33.97% decrease from a year earlier, with the FY2025 full-year figure at $55550.0, down 64.04% from the prior year.
- Payables was $63050.0 for Q2 2026 at Acro Biomedical, up from $55550.0 in the prior quarter.
- The five-year high for Payables was $155507.0 in Q3 2024, with the low at $21029.0 in Q1 2022.
- Average Payables over 5 years is $113165.7, with a median of $127786.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Payables sank 92.26% in 2022, then surged 507.67% in 2023.
- Over 5 years, Payables stood at $155397.0 in 2022, then decreased by 0.61% to $154444.0 in 2023, then grew by 0.01% to $154460.0 in 2024, then plunged by 64.04% to $55550.0 in 2025, then gained by 13.5% to $63050.0 in 2026.
- The last three Payables figures came in at $63050.0 (Q2 2026), $55550.0 (Q4 2025), and $116582.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 2.15 Bn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 2.58 Bn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 3.80 Bn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 676.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | 22.79 Mn |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 486.60 Mn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 101.30 Mn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 264.90 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | 4.38 Mn |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | 63,050.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63,050.00 |
| Dec 31, 2025 | 55,550.00 |
| Sep 30, 2025 | 116,582.00 |
| Jun 30, 2025 | 95,493.00 |
| Mar 31, 2025 | 143,178.00 |
| Dec 31, 2024 | 154,460.00 |
| Sep 30, 2024 | 155,507.00 |
| Jun 30, 2024 | 152,736.00 |
| Mar 31, 2024 | 152,294.00 |
| Dec 31, 2023 | 154,444.00 |
| Sep 30, 2023 | 153,036.00 |
| Jun 30, 2023 | 87,536.00 |
| Mar 31, 2023 | 127,786.00 |
| Dec 31, 2022 | 155,397.00 |
| Sep 30, 2022 | 99,494.00 |
| Jun 30, 2022 | 36,245.00 |
| Mar 31, 2022 | 21,029.00 |
| Dec 31, 2021 | 46,938.00 |
| Sep 30, 2021 | 35,722.00 |
| Jun 30, 2021 | 28,004.00 |